000			02073 a2200601 4500
005			20250515094005.0
264		0	_c20080416
008			200804s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdm522 _2doi
040			_aNLM _beng _cNLM
100	1		_aEralp, Y
245	0	0	_aMAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cApr 2008
300			_a669-74 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnthracyclines _xpharmacology
650	0	4	_aAntibiotics, Antineoplastic _xpharmacology
650	0	4	_aBiomarkers, Tumor _xanalysis
650	0	4	_aBreast Neoplasms _xchemistry
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aErbB Receptors _xanalysis
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Enzymologic
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aMiddle Aged
650	0	4	_aMitogen-Activated Protein Kinases _xanalysis
650	0	4	_aNeoplasm Recurrence, Local _xchemistry
650	0	4	_aOdds Ratio
650	0	4	_aPhosphatidylinositol 3-Kinases _xanalysis
650	0	4	_aPrognosis
650	0	4	_aProportional Hazards Models
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aUp-Regulation
700	1		_aDerin, D
700	1		_aOzluk, Y
700	1		_aYavuz, E
700	1		_aGuney, N
700	1		_aSaip, P
700	1		_aMuslumanoglu, M
700	1		_aIgci, A
700	1		_aKücücük, S
700	1		_aDincer, M
700	1		_aAydiner, A
700	1		_aTopuz, E
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 19 _gno. 4 _gp. 669-74
856	4	0	_uhttps://doi.org/10.1093/annonc/mdm522 _zAvailable from publisher's website
999			_c17523713 _d17523713